Towards better decision making in growth hormone therapy.

J S Pliskin
Author Information
  1. J S Pliskin: Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Abstract

Controlled clinical trials are not always possible or warranted. Other sources of data include observational studies, meta-analyses, expert opinions, subjective judgements, and mathematical/statistical models developed from large databases. Decision analysis is presented as a preferred methodology for analysis in situations of uncertainty, in combination with cost-benefit and cost-effectiveness analyses. Special emphasis is given to quality-of-life considerations in growth hormone (GH) therapy and ways to measure it and express patient preferences.

MeSH Term

Body Height
Child
Clinical Trials as Topic
Cost-Benefit Analysis
Databases as Topic
Decision Making
Decision Support Systems, Clinical
Evidence-Based Medicine
Growth Disorders
Human Growth Hormone
Humans
Internet
Models, Statistical
Quality of Life
United States

Chemicals

Human Growth Hormone

Word Cloud

Created with Highcharts 10.0.0analysisgrowthhormonetherapyControlledclinicaltrialsalwayspossiblewarrantedsourcesdataincludeobservationalstudiesmeta-analysesexpertopinionssubjectivejudgementsmathematical/statisticalmodelsdevelopedlargedatabasesDecisionpresentedpreferredmethodologysituationsuncertaintycombinationcost-benefitcost-effectivenessanalysesSpecialemphasisgivenquality-of-lifeconsiderationsGHwaysmeasureexpresspatientpreferencesTowardsbetterdecisionmaking

Similar Articles

Cited By